Top compounds associated with response to ADGRG1


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.013 0.8
mRNA tivozanib GDSC1000 pan-cancer AAC -0.054 0.2
mRNA tivozanib CTRPv2 pan-cancer AAC -0.036 0.4
mRNA tosedostat CTRPv2 pan-cancer AAC -0.064 0.1
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.094 0.003
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.025 0.5
mRNA triptolide CTRPv2 pan-cancer AAC -0.064 0.08
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.059 0.1
Download CSV